- Report
- July 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
The Semi Solid Dosage Contract Manufacturing market in the pharmaceutical industry involves third-party companies specializing in the production of semi-solid forms of medication, such as creams, ointlets, gels, and pastes. These contract manufacturers provide expertise and capacity for pharmaceutical companies that prefer to outsource the production of these dosage forms. They often offer a range of services including product development, formulating, mixing, filling, and packaging, adhering to regulatory standards and quality control measures. The demand for contract manufacturing in semi-solid dosage forms is driven by the need for specialized equipment and processes, as well as the expertise required to ensure product consistency, stability, and effectiveness.
The landscape of semi-solid dosage contract manufacturing is comprised of various firms, ranging from large multinational organizations to specialized niche companies. Some notable companies in this market include Catalent Inc., which offers comprehensive drug development and manufacturing services, Thermo Fisher Scientific with its array of pharmaceutical services, including formulation and production of semi-solid dosage forms, and Perrigo Company plc, known for its expertise in over-the-counter pharmaceuticals and consumer products. Additionally, Recipharm AB and DPT Laboratories are also key players, providing tailored solutions for semi-solid drug development and manufacturing. Show Less Read more